Shareholding disclosure

Omega Fund IV LP

Declared position

4.72%

Threshold

Crossed upwards

Timeline

Published

24.08.2012

Transaction

20.08.2012

Transfer date

27.08.2012

Voting rights breakdown

Voting rights acquired4.72%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAC8N00022

Beneficial owner

Omega Fund IV LP

Declared address

Omega Fund IV L.P., Boston, MA 02116

Purchase of shares in a private placement

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Omega Fund IV LP

Newron Pharmaceuticals S.p.A.24.08.2012TAC8N00022

Disclosure summary

Omega Fund IV LP disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 24.08.2012, at 4.72% of voting rights. Notice category: Single shareholder.

Disclosed position

4.72%

Voting rights acquired

Voting rights acquired4.72%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Omega Fund IV LP disclosed a holding in Newron Pharmaceuticals S.p.A., published on 24.08.2012.

Publication date24.08.2012

Transaction date20.08.2012

Transfer date27.08.2012

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerOmega Fund IV LP

Declared addressOmega Fund IV L.P., Boston, MA 02116

CategorySingle shareholder

Voting rights acquired4.72%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAC8N00022

Conditions

Purchase of shares in a private placement

Source: SIX Exchange Regulation · Publication date: 24.08.2012

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open